rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2003-3-13
|
pubmed:abstractText |
This randomized, double-blind, placebo-controlled trial examined the efficacy and safety of risperidone in the treatment of aggression, agitation, and psychosis in elderly nursing-home patients with dementia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0160-6689
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
134-43
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12633121-Aged,
pubmed-meshheading:12633121-Aggression,
pubmed-meshheading:12633121-Alzheimer Disease,
pubmed-meshheading:12633121-Antipsychotic Agents,
pubmed-meshheading:12633121-Basal Ganglia Diseases,
pubmed-meshheading:12633121-Dementia, Vascular,
pubmed-meshheading:12633121-Double-Blind Method,
pubmed-meshheading:12633121-Female,
pubmed-meshheading:12633121-Homes for the Aged,
pubmed-meshheading:12633121-Humans,
pubmed-meshheading:12633121-Male,
pubmed-meshheading:12633121-Placebos,
pubmed-meshheading:12633121-Psychiatric Status Rating Scales,
pubmed-meshheading:12633121-Psychomotor Agitation,
pubmed-meshheading:12633121-Research Design,
pubmed-meshheading:12633121-Risperidone,
pubmed-meshheading:12633121-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
|
pubmed:affiliation |
Academic Department for Old Age Psychiatry, School of Psychiatry, University of New South Wales, Sydney, Australia. h.brodaty@unsw.edu.au
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|